Guasch Antonio, Navarrete Jose, Nass Kaleed, Zayas Carlos F
Renal Division, Emory University, Room 338, 1639 Pierce Drive, Atlanta, GA 30322, USA.
J Am Soc Nephrol. 2006 Aug;17(8):2228-35. doi: 10.1681/ASN.2002010084. Epub 2006 Jul 12.
Patients with sickle cell anemia (SCA) may develop a glomerulopathy with proteinuria and progressive renal insufficiency, leading to ESRD. Albuminuria is a sensitive marker of glomerular damage in this population and precedes the development of renal insufficiency. For determination of the prevalence of glomerular damage in SCA and the clinical correlates of renal insufficiency, 300 adult patients with SCA were studied (hemoglobin SS = 184; and 116 with other sickling hemoglobinopathies: SC, SD, and S-beta thalassemia); albumin excretion rates (AER) and renal function (Cockroft-Gault formula) were determined, and clinical and hematologic evaluations were conducted. In hemoglobin SS disease, increased AER (micro- and macroalbuminuria) occurred in 68% of adult patients, and macroalbuminuria occurred in 26%. In other sickling disorders, increased AER occurs in 32% of adults, and macroalbuminuria occurs in 10%. The development of graded albuminuria was age dependent, so at 40 yr, 40% of patients with SS disease had macroalbuminuria. There were no differences in hematologic parameters (hemoglobin levels, white blood cell count, percentage of reticulocytes, platelet counts, or lactate dehydrogenase levels) between patients with normoalbuminuria and those with micro- or macroalbuminuria. By multivariate analysis, albuminuria correlated with age and serum creatinine in SS disease but not with BP or hemoglobin levels. In other sickling disorders, albuminuria tended to be associated with age but not with hemoglobin or BP levels. The diastolic BP was lower in patients with SCA than in African American control subjects, and the development of renal insufficiency, which was present in 21% of adults with SS disease, was not accompanied by significant hypertension. It is concluded that glomerular damage in adults with SCA is very common, and a majority of patients with SS disease are at risk for the development of progressive renal failure. The development of micro- and macroalbuminuria is not related to the degree of anemia, suggesting that sickle cell glomerulopathy is not solely related to hemodynamic adaptations to chronic anemia. In contrast to other glomerulopathies, the development of systemic hypertension is uncommon in SS disease with renal insufficiency.
镰状细胞贫血(SCA)患者可能会出现伴有蛋白尿和进行性肾功能不全的肾小球病,最终导致终末期肾病(ESRD)。蛋白尿是该人群肾小球损伤的敏感标志物,且早于肾功能不全的发生。为了确定SCA中肾小球损伤的患病率以及肾功能不全的临床相关因素,对300例成年SCA患者进行了研究(血红蛋白SS型 = 184例;其他镰状血红蛋白病116例:SC、SD和S-β地中海贫血);测定了白蛋白排泄率(AER)和肾功能(Cockcroft-Gault公式),并进行了临床和血液学评估。在血红蛋白SS病中,68%的成年患者出现AER升高(微量和大量蛋白尿),26%出现大量蛋白尿。在其他镰状疾病中,32%的成年人出现AER升高,10%出现大量蛋白尿。分级蛋白尿的发生与年龄相关,因此在40岁时,40%的SS病患者出现大量蛋白尿。正常蛋白尿患者与微量或大量蛋白尿患者在血液学参数(血红蛋白水平、白细胞计数、网织红细胞百分比、血小板计数或乳酸脱氢酶水平)上无差异。多因素分析显示,在SS病中,蛋白尿与年龄和血清肌酐相关,但与血压或血红蛋白水平无关。在其他镰状疾病中,蛋白尿往往与年龄相关,但与血红蛋白或血压水平无关。SCA患者的舒张压低于非裔美国对照受试者,21%的SS病成年患者出现肾功能不全,且未伴有明显高血压。结论是,成年SCA患者的肾小球损伤非常常见,大多数SS病患者有发生进行性肾衰竭的风险。微量和大量蛋白尿的发生与贫血程度无关,提示镰状细胞肾小球病并非仅与对慢性贫血的血流动力学适应有关。与其他肾小球病不同,在伴有肾功能不全的SS病中,系统性高血压并不常见。